Pasithea Gross Profit from 2010 to 2025

KTTAW Stock

USD 0.02 0 9.89%

Pasithea Therapeutics Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit Pasithea Therapeutics Corp makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

-583.6 K

Current Value

-554.4 K

Quarterly Volatility

268.1 K

Credit Downgrade

Yuan Drop

Covid

Check Pasithea Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pasithea Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 783 K, Other Operating Expenses of 9.9 M or Total Operating Expenses of 9.8 M, as well as many indicators such as Price To Sales Ratio of 36.39, Dividend Yield of 0.0 or PTB Ratio of 0.44. Pasithea financial statements analysis is a perfect complement when working with Pasithea Therapeutics Valuation or Volatility modules.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Latest Pasithea Therapeutics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Pasithea Therapeutics Corp over the last few years. Gross profit is a required income statement account that reflects total revenue of Pasithea Therapeutics Corp minus its cost of goods sold. It is profit before Pasithea Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Pasithea Therapeutics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pasithea Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Pasithea Gross Profit Regression Statistics

	Arithmetic Mean	(89,980)
	Coefficient Of Variation	(297.99)
	Mean Deviation	189,569
	Median	(2,213)
	Standard Deviation	268,129
	Sample Variance	71.9B
	Range	1M
	R-Value	(0.51)
	Mean Square Error	56.9B
	R-Squared	0.26
	Significance	0.04
	Slope	(28,779)
	Total Sum of Squares	1.1T

Pasithea Gross Profit History

	2025	-554.4 K
	2024	-583.6 K
	2023	-648.5 K
	2022	373.4 K

Other Fundumenentals of Pasithea Therapeutics

Gross Profit Margin

Pasithea Therapeutics Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Current Deferred Revenue	Net Receivables	Short Term Debt	Intangible Assets
Total Assets		1.0	-0.95	-0.66	0.69	0.89	1.0	0.98	-0.34	0.97	-0.34	-0.47	-0.48	-0.47	-0.47
Total Stockholder Equity	1.0		-0.96	-0.63	0.67	0.87	1.0	0.99	-0.31	0.98	-0.31	-0.44	-0.46	-0.44	-0.45
Net Debt	-0.95	-0.96		0.41	-0.44	-0.73	-0.96	-0.98	0.08	-0.98	0.08	0.23	0.23	0.23	0.21
Retained Earnings	-0.66	-0.63	0.41		-0.98	-0.9	-0.63	-0.52	0.87	-0.47	0.87	0.93	0.93	0.93	0.82
Accounts Payable	0.69	0.67	-0.44	-0.98		0.89	0.67	0.56	-0.89	0.52	-0.89	-0.92	-0.94	-0.93	-0.9
Total Liab	0.89	0.87	-0.73	-0.9	0.89		0.87	0.79	-0.64	0.75	-0.64	-0.73	-0.75	-0.76	-0.65
Net Invested Capital	1.0	1.0	-0.96	-0.63	0.67	0.87		0.99	-0.31	0.98	-0.31	-0.44	-0.46	-0.44	-0.45
Total Current Assets	0.98	0.99	-0.98	-0.52	0.56	0.79	0.99		-0.22	1.0	-0.22	-0.35	-0.36	-0.34	-0.38
Capital Stock	-0.34	-0.31	0.08	0.87	-0.89	-0.64	-0.31	-0.22		-0.18	1.0	0.98	0.99	0.98	0.9
Net Working Capital	0.97	0.98	-0.98	-0.47	0.52	0.75	0.98	1.0	-0.18		-0.18	-0.31	-0.32	-0.3	-0.35
Common Stock	-0.34	-0.31	0.08	0.87	-0.89	-0.64	-0.31	-0.22	1.0	-0.18		0.98	0.99	0.98	0.9
Current Deferred Revenue	-0.47	-0.44	0.23	0.93	-0.92	-0.73	-0.44	-0.35	0.98	-0.31	0.98		0.99	0.97	0.87
Net Receivables	-0.48	-0.46	0.23	0.93	-0.94	-0.75	-0.46	-0.36	0.99	-0.32	0.99	0.99		0.99	0.92
Short Term Debt	-0.47	-0.44	0.23	0.93	-0.93	-0.76	-0.44	-0.34	0.98	-0.3	0.98	0.97	0.99		0.87
Intangible Assets	-0.47	-0.45	0.21	0.82	-0.9	-0.65	-0.45	-0.38	0.9	-0.35	0.9	0.87	0.92	0.87

Click cells to compare fundamentals

About Pasithea Therapeutics Financial Statements

Pasithea Therapeutics investors use historical fundamental indicators, such as Pasithea Therapeutics' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pasithea Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	-583.6 K	-554.4 K
Gross Profit Margin	0.69	0.73

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Pasithea Stock Analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC